- Diagnostic Différentiel
- Essayez d'établir votre recherche sur un attribut à la fois, et soyez aussi spécifique que possible! Exemple : "toux chronique".
- Ne pas entrer les résultats multiples tels que "anémie, toux chronique, perte de poids, vomissant" tous en même temps.
- Après sélection de votre attribut, une liste de diagnostics possibles sera générée. Si la liste est trop longue, vous pourrez la réduire en écrivant des attribut additionnels.
- Ne pas écrire les valeurs telles que le "rythme cardiaque 110" ou le "sodium 125", mais plutôt "tachycardie" ou "hyponatrémie".
Drug Information for Strattera (Physicians Total Care, Inc.): 17 PATIENT COUNSELING INFORMATION
- 1 INDICATIONS AND USAGE
- 2 DOSAGE AND ADMINISTRATION
- 3 DOSAGE FORMS AND STRENGTHS
- 4 CONTRAINDICATIONS
- 5 WARNINGS AND PRECAUTIONS
- 6 ADVERSE REACTIONS
- 7 DRUG INTERACTIONS
- 8 USE IN SPECIFIC POPULATIONS
- 9 DRUG ABUSE AND DEPENDENCE
- 10 OVERDOSAGE
- 11 DESCRIPTION
- 12 CLINICAL PHARMACOLOGY
- 13 NONCLINICAL TOXICOLOGY
- 14 CLINICAL STUDIES
- 16 HOW SUPPLIED/STORAGE AND HANDLING
- 17 PATIENT COUNSELING INFORMATION
- PRINCIPAL DISPLAY PANEL
- Liens externes liés à Strattera (Physicians Total Care, Inc.)
See FDA-approved Medication Guide.17.1 General Information
Physicians should instruct their patients to read the Medication Guide before starting therapy with STRATTERA and to reread it each time the prescription is renewed.
Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with STRATTERA and should counsel them in its appropriate use. The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents. Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have.
Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking STRATTERA.17.2 Suicide Risk
Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, depression, and suicidal ideation, especially early during STRATTERA treatment and when the dose is adjusted. Families and caregivers of patients should be advised to observe for the emergence of such symptoms on a day–to–day basis, since changes may be abrupt. Such symptoms should be reported to the patient’s prescriber or health professional, especially if they are severe, abrupt in onset, or were not part of the patient’s presenting symptoms. Symptoms such as these may be associated with an increased risk for suicidal thinking and behavior and indicate a need for very close monitoring and possibly changes in the medication.17.3 Severe Liver Injury
Patients initiating STRATTERA should be cautioned that severe liver injury may develop. Patients should be instructed to contact their physician immediately should they develop pruritus, dark urine, jaundice, right upper quadrant tenderness, or unexplained “flu–like” symptoms [see Warnings and Precautions (5.2)].17.4 Aggression or Hostility
Patients should be instructed to call their doctor as soon as possible should they notice an increase in aggression or hostility.17.5 Priapism
Rare postmarketing cases of priapism, defined as painful and nonpainful penile erection lasting more than 4 hours, have been reported for pediatric and adult patients treated with STRATTERA. The parents or guardians of pediatric patients taking STRATTERA and adult patients taking STRATTERA should be instructed that priapism requires prompt medical attention.17.6 Ocular Irritant
STRATTERA is an ocular irritant. STRATTERA capsules are not intended to be opened. In the event of capsule content coming in contact with the eye, the affected eye should be flushed immediately with water, and medical advice obtained. Hands and any potentially contaminated surfaces should be washed as soon as possible.17.7 Drug-Drug Interaction
Patients should be instructed to consult a physician if they are taking or plan to take any prescription or over–the–counter medicines, dietary supplements, or herbal remedies.17.8 Pregnancy
Patients should be instructed to consult a physician if they are nursing, pregnant, or thinking of becoming pregnant while taking STRATTERA.17.9 Food
Patients may take STRATTERA with or without food.17.10 Missed Dose
If patients miss a dose, they should be instructed to take it as soon as possible, but should not take more than the prescribed total daily amount of STRATTERA in any 24–hour period.17.11 Interference with Psychomotor Performance
Patients should be instructed to use caution when driving a car or operating hazardous machinery until they are reasonably certain that their performance is not affected by atomoxetine.
Literature revised June 3, 2009
Eli Lilly and Company
Indianapolis, IN 46285, USA
Copyright © 2002, 2009, Eli Lilly and Company. All rights reserved.
PV 6264 AMP
MEDICATION GUIDE STRATTERA® (Stra-TAIR-a)(atomoxetine hydrochloride)
Read the Medication Guide that comes with STRATTERA® before you or your child starts taking it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking to your doctor about your treatment or your child’s treatment with STRATTERA.
The following have been reported with use of STRATTERA:
Children and teenagers sometimes think about suicide, and many report trying to kill themselves. Results from STRATTERA clinical studies with over 2200 child or teenage ADHD patients suggest that some children and teenagers may have a higher chance of having suicidal thoughts or actions. Although no suicides occurred in these studies, 4 out of every 1000 patients developed suicidal thoughts. Tell your child or teenager’s doctor if your child or teenager (or there is a family history of):
has bipolar illness (manic-depressive illness)
had suicide thoughts or actions before starting STRATTERA
The chance for suicidal thoughts and actions may be higher:
early during STRATTERA treatment
during dose adjustments
Prevent suicidal thoughts and action in your child or teenager by:
paying close attention to your child or teenager’s moods, behaviors, thoughts, and feelings during STRATTERA treatment
keeping all follow-up visits with your child or teenager’s doctor as scheduled
Watch for the following signs in your child or teenager during STRATTERA treatment:
Call your child or teenager’s doctor right away if they have any of the above signs, especially if they are new, sudden, or severe. Your child or teenager may need to be closely watched for suicidal thoughts and actions or need a change in medicine.
STRATTERA can cause liver injury in some patients. Call your doctor right away if you or your child has the following signs of liver problems:
right upper belly pain
yellow skin or eyes
unexplained flu-like symptoms
sudden death in patients who have heart problems or heart defects
stroke and heart attack in adults
increased blood pressure and heart rate
Tell your doctor if you or your child has any heart problems, heart defects, high blood pressure, or a family history of these problems. Your doctor should check you or your child carefully for heart problems before starting STRATTERA.
Your doctor should check your blood pressure or your child’s blood pressure and heart rate regularly during treatment with STRATTERA.
Call your doctor right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting while taking STRATTERA.
new psychotic symptoms (such as hearing voices, believing things that are not true, being suspicious) or new manic symptoms
Call your child or teenager’s doctor right away about any new mental symptoms because adjusting or stopping STRATTERA treatment may need to be considered.
What Is STRATTERA?
STRATTERA is a selective norepinephrine reuptake inhibitor medicine. It is used for the treatment of attention deficit and hyperactivity disorder (ADHD). STRATTERA may help increase attention and decrease impulsiveness and hyperactivity in patients with ADHD.
STRATTERA should be used as a part of a total treatment program for ADHD that may include counseling or other therapies.
STRATTERA has not been studied in children less than 6 years old.
Who should not take STRATTERA?
STRATTERA should not be taken if you or your child:
are taking or have taken within the past 14 days an anti-depression medicine called a monoamine oxidase inhibitor or MAOI. Some names of MAOI medicines are Nardil® (phenelzine sulfate), Parnate® (tranylcypromine sulfate) and Emsam® (selegiline transdermal system).
have an eye problem called narrow angle glaucoma
are allergic to anything in STRATTERA. See the end of this Medication Guide for a complete list of ingredients.
STRATTERA may not be right for you or your child. Before starting STRATTERA tell your doctor or your child’s doctor about all health conditions (or a family history of) including:
have or had suicide thoughts or actions
heart problems, heart defects, irregular heart beat, high blood pressure, or low blood pressure
mental problems, psychosis, mania, bipolar illness, or depression
Tell your doctor if you or your child is pregnant, planning to become pregnant, or breastfeeding.
Can STRATTERA be taken with other medicines?
Tell your doctor about all the medicines that you or your child takes including prescription and nonprescription medicines, vitamins, and herbal supplements. STRATTERA and some medicines may interact with each other and cause serious side effects. Your doctor will decide whether STRATTERA can be taken with other medicines.
Especially tell your doctor if you or your child takes:
anti-depression medicines including MAOIs
blood pressure medicines
cold or allergy medicines that contain decongestants
Know the medicines that you or your child takes. Keep a list of your medicines with you to show your doctor and pharmacist.
Do not start any new medicine while taking STRATTERA without talking to your doctor first.
How should STRATTERA be taken?
Take STRATTERA exactly as prescribed. STRATTERA comes in different dose strength capsules. Your doctor may adjust the dose until it is right for you or your child.
Do not chew, crush, or open the capsules. Swallow STRATTERA capsules whole with water or other liquids. Tell your doctor if you or your child cannot swallow STRATTERA whole. A different medicine may need to be prescribed.
Avoid touching a broken STRATTERA capsule. Wash hands and surfaces that touched an open STRATTERA capsule. If any of the powder gets in your eyes or your child’s eyes, rinse them with water right away and call your doctor.
STRATTERA can be taken with or without food.
STRATTERA is usually taken once or twice a day. Take STRATTERA at the same time each day to help you remember. If you miss a dose of STRATTERA, take it as soon as you remember that day. If you miss a day of STRATTERA, do not double your dose the next day. Just skip the day you missed.
From time to time, your doctor may stop STRATTERA treatment for a while to check ADHD symptoms.
- Your doctor may do regular checks of the blood, heart, and blood pressure while taking STRATTERA. Children should have their height and weight checked often while taking STRATTERA. STRATTERA treatment may be stopped if a problem is found during these check-ups.
If you or your child takes too much STRATTERA or overdoses, call your doctor or poison control center right away, or get emergency treatment.
What are possible side effects of STRATTERA?
See “What is the most important information I should know about STRATTERA?” for information on reported suicidal thoughts and actions, other mental problems, severe liver damage, and heart problems.
Other serious side effects include:
serious allergic reactions (call your doctor if you see swelling, hives, or experience other allergic reactions)
slowing of growth (height and weight) in children
problems passing urine including
trouble starting or keeping a urine stream
cannot fully empty the bladder
Common side effects in children and teenagers include:
nausea or vomiting
Common side effects in adults include:
sexual side effects
problems passing urine
Other information for children, teenagers, and adults:
Erections that won’t go away (priapism) have occurred rarely during treatment with STRATTERA. If you have an erection that lasts more than 4 hours, seek medical help right away. Because of the potential for lasting damage, including the potential inability to have erections, priapism should be evaluated by a doctor immediately.
STRATTERA may affect your ability or your child’s ability to drive or operate heavy machinery. Be careful until you know how STRATTERA affects you or your child.
Talk to your doctor if you or your child has side effects that are bothersome or do not go away.
This is not a complete list of possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store STRATTERA?
Store STRATTERA in a safe place at room temperature, 59 to 86°F (15 to 30°C).
Keep STRATTERA and all medicines out of the reach of children.
General information about STRATTERA
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use STRATTERA for a condition for which it was not prescribed. Do not give STRATTERA to other people, even if they have the same condition. It may harm them.
This Medication Guide summarizes the most important information about STRATTERA. If you would like more information, talk with your doctor. You can ask your doctor or pharmacist for information about STRATTERA that was written for healthcare professionals. For more information about STRATTERA call 1–800–Lilly–Rx (1–800–545–5979) or visit www.strattera.com.
What are the ingredients in STRATTERA?
Active ingredient: atomoxetine hydrochloride.
Inactive ingredients: pregelatinized starch, dimethicone, gelatin, sodium lauryl sulfate, FD&C Blue No. 2, synthetic yellow iron oxide, titanium dioxide, red iron oxide, and edible black ink.
Nardil® is a registered trademark of Pfizer Inc.
Parnate® is a registered trademark of GlaxoSmithKline.
Emsam® is a registered trademark of Somerset Pharmaceuticals Inc.This Medication Guide has been approved by the US Food and Drug Administration.
Patient Information revised July 23, 2008
Eli Lilly and Company
Indianapolis, IN 46285, USA
Copyright © 2003, 2008, Eli Lilly and Company. All rights reserved.
PV 5854 AMP
- Drug Information Provided by National Library of Medicine (NLM).